Bufalin reverses multidrug resistance by regulating stemness through the CD133/nuclear factor‐κB/MDR1 pathway in colorectal cancer

Abstract excerpt

Recent studies have shown that MDR could be induced by the high stemness of cancer cells. In a previous study, we found bufalin could reverse MDR and inhibit cancer cell stemness in colorectal cancer, but the relationship between them was unclear. Here we identified overexpressing CD133 increases levels of Akt/nuclear factor-κB signaling mediators and MDR1, while increasing cell chemoresistance. Furthermore,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bioactive Compounds and Antitumor Agents
• Share to Cancer Cells and Metastasis
• Share to Cancer therapeutics and mechanisms